XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisition of Visimid Technologies (Details Narrative) - Acquisition of Visimid Technologies [Member] - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Oct. 23, 2023
Jul. 31, 2023
Dec. 31, 2023
Jun. 30, 2023
Dec. 31, 2023
Acquisition price of company in cash   $ 1,000,000      
Goodwill adjustment amount   2,200,000      
Bank debt   150,000      
Purchase acquisition of restricted stock   $ 1,550,000      
Description of restricted stock installments   Of the restricted stock payable as part of the purchase price, $150,000 (81,610 shares) was issued at closing, with the balance to be issued in four equal installments of $350,000 each, on January 1, 2024, July 1, 2024, January 1, 2025 and July 1, 2025      
Purchase price net acquisition cost $ 150,000,000,000 $ 2,700,000 $ 13,000 $ 140,000,000,000 $ 97,000
Acquisition payment amount at the closing period         600,000
Trade Secrets [Member]          
Estimated fair values of the assets acquired and liabilities assumed         925,000
Trademarks [Member]          
Estimated fair values of the assets acquired and liabilities assumed         442,000
Customer Backlog [Member]          
Estimated fair values of the assets acquired and liabilities assumed         $ 464,000
Estimated useful lives of assets         1 year
Customer Relationships [Member]          
Estimated fair values of the assets acquired and liabilities assumed         $ 122,000
Estimated useful lives of assets         10 years